Progression-free and overall survival of patients with advanced or metastatic pancreatic cancer in German outpatient centers – first outcome data from the clinical TPK Registry. 7. Juni 2015 Hegewisch-Becker, S., Hofheinz, R., Wolf, T., Aldaoud, A., Harde, J., Kopfmann, S., Marschner, N., 2015. Oncol Res Treat 38 (suppl 5)(V26), 5. doi:10.1159/000439070 Abstract Maintenance strategies after first-line oxaliplatin plus fluoropyrimidine plus bevacizumab for patients with metastatic colorectal cancer (AIO 0207): a randomised, non-inferiority, open-label, phase 3 trial. Hegewisch-Becker, S., Graeven, U., Lerchenmüller, C.A., Killing, B., Depenbusch, R., Steffens, C.-C., Al-Batran, S.-E., Lange, T., Dietrich, G., Stoehlmacher, J., Tannapfel, A., Reinacher-Schick, A., Quidde,… Weiterlesen 1st-line treatment of patients with high-grade non-Hodgkin’s lymphoma: Similar effectiveness with R-CHOP-14 or R-CHOP-21 – Data from the German prospective TLN Registry. Knauf, W., Abenhardt, W., Mohm, J., Rauh, J., Grugel, R., Harde, J., Jänicke, M., Marschner, N., 2015. Oncol Res Treat 38 (suppl 5)(V75), 19. doi:10.1159/000439070… Weiterlesen